JP2020529847A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529847A5 JP2020529847A5 JP2020505464A JP2020505464A JP2020529847A5 JP 2020529847 A5 JP2020529847 A5 JP 2020529847A5 JP 2020505464 A JP2020505464 A JP 2020505464A JP 2020505464 A JP2020505464 A JP 2020505464A JP 2020529847 A5 JP2020529847 A5 JP 2020529847A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- immune cells
- types
- cells
- lymphocytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762540901P | 2017-08-03 | 2017-08-03 | |
| US62/540,901 | 2017-08-03 | ||
| PCT/US2018/044740 WO2019028098A1 (en) | 2017-08-03 | 2018-08-01 | METHODS AND COMPOSITIONS FOR TREATING CANCER |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020529847A JP2020529847A (ja) | 2020-10-15 |
| JP2020529847A5 true JP2020529847A5 (https=) | 2021-09-09 |
Family
ID=65234162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505464A Pending JP2020529847A (ja) | 2017-08-03 | 2018-08-01 | がんの処置のための方法および組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20200155600A1 (https=) |
| EP (1) | EP3661953A4 (https=) |
| JP (1) | JP2020529847A (https=) |
| KR (1) | KR20200036874A (https=) |
| CN (1) | CN111094328A (https=) |
| AU (1) | AU2018308982A1 (https=) |
| CA (1) | CA3071448A1 (https=) |
| IL (1) | IL272147A (https=) |
| SG (1) | SG11202000724XA (https=) |
| WO (1) | WO2019028098A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113874033A (zh) * | 2019-04-08 | 2021-12-31 | 泰加生物工艺学公司 | 用于冷冻保存免疫细胞的组合物和方法 |
| EP3969041A4 (en) * | 2019-05-14 | 2023-05-10 | Taiga Biotechnologies, Inc. | COMPOSITIONS AND METHODS FOR TREATMENT OF T-CELL DEPLETION |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6358739B1 (en) * | 1999-04-12 | 2002-03-19 | Modex Therapeutiques, S.A. | Transiently immortalized cells |
| US20040241140A1 (en) * | 2000-11-01 | 2004-12-02 | Pavlakis George N. | Expression vectors able to elicit improved immune response and methods of using same |
| US20030216315A1 (en) * | 2002-02-13 | 2003-11-20 | Duke University | Modulation of immune response by non-peptide binding stress response polypeptides |
| WO2005084158A2 (en) * | 2003-06-20 | 2005-09-15 | The Regents Of The University Of California | Polypeptide transduction and fusogenic peptides |
| IL296832A (en) * | 2005-10-18 | 2022-11-01 | Nat Jewish Health | Process of preparing red blood cells using conditionally immortalized long-term hematopoietic stem cells and erythropoietin |
| DK3339321T3 (da) * | 2008-08-28 | 2021-06-21 | Taiga Biotechnologies Inc | Modulatorer af myc, fremgangsmåder til anvendelse af samme og fremgangsmåder til at identificere stoffer der modulerer myc |
| US9789135B2 (en) * | 2012-07-20 | 2017-10-17 | Taiga Biotechnologies, Inc. | Enhanced reconstitution and autoreconstitution of the hematopoietic compartment |
| US9365825B2 (en) * | 2013-03-11 | 2016-06-14 | Taiga Biotechnologies, Inc. | Expansion of adult stem cells in vitro |
| DK2986311T3 (en) * | 2013-04-18 | 2019-02-25 | Tilt Biotherapeutics Oy | IMPROVED ADOPTIVE CELL THERAPY |
| ES2905757T3 (es) * | 2017-08-03 | 2022-04-12 | Taiga Biotechnologies Inc | Métodos y composiciones para el tratamiento del melanoma |
| US10149898B2 (en) * | 2017-08-03 | 2018-12-11 | Taiga Biotechnologies, Inc. | Methods and compositions for the treatment of melanoma |
-
2018
- 2018-08-01 KR KR1020207004465A patent/KR20200036874A/ko not_active Ceased
- 2018-08-01 WO PCT/US2018/044740 patent/WO2019028098A1/en not_active Ceased
- 2018-08-01 SG SG11202000724XA patent/SG11202000724XA/en unknown
- 2018-08-01 CA CA3071448A patent/CA3071448A1/en active Pending
- 2018-08-01 US US16/635,383 patent/US20200155600A1/en not_active Abandoned
- 2018-08-01 AU AU2018308982A patent/AU2018308982A1/en not_active Abandoned
- 2018-08-01 EP EP18841366.0A patent/EP3661953A4/en not_active Withdrawn
- 2018-08-01 CN CN201880057363.5A patent/CN111094328A/zh active Pending
- 2018-08-01 JP JP2020505464A patent/JP2020529847A/ja active Pending
-
2020
- 2020-01-20 IL IL272147A patent/IL272147A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sun et al. | Eradication of hepatocellular carcinoma by NKG2D-based CAR-T cells | |
| US20220098300A1 (en) | Anti trbc1 antigen binding domains | |
| Kiesgen et al. | Chimeric antigen receptor (CAR) T-cell therapy for thoracic malignancies | |
| JP2021058197A5 (https=) | ||
| CN118546960A (zh) | Cd19定向性嵌合抗原受体及其在免疫疗法中的用途 | |
| US11970545B2 (en) | T cell-antigen coupler with Y182T mutation and methods of uses thereof | |
| WO2021048724A1 (en) | Combined expression of a chimeric cd3 fusion protein and an anti-cd3-based bispecific t cell activating element | |
| Franks et al. | New anticancer immunotherapies | |
| JP2020516681A5 (https=) | ||
| JP2022512541A5 (https=) | ||
| JP2019515653A5 (https=) | ||
| IL301995A (en) | Cells comprising t cell-antigen couplers and uses thereof | |
| JP2021512637A5 (https=) | ||
| JP2021525068A5 (https=) | ||
| JP2020529847A5 (https=) | ||
| Long et al. | HLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in mice | |
| CN115023237A (zh) | 癌症或肿瘤的治疗方法 | |
| JP2022506781A5 (https=) | ||
| WO2022033483A1 (zh) | 多功能的免疫效应细胞及其应用 | |
| JP2022547809A5 (https=) | ||
| WO2023283361A1 (en) | Gpc3 t cell-antigen couplers and uses thereof | |
| Snook et al. | GUCY2C-targeted cancer immunotherapy: past, present and future | |
| JP2024535781A (ja) | 抗原結合タンパク質およびその使用 | |
| US12479903B2 (en) | CD5 specific T cell receptor cell or gene therapy | |
| JP2022503621A5 (https=) |